创新生物药，惠及患者
信达生物制药 (Innovent Biologics) (innoventbio.com) scores 67 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, in the 15th percentile of 13258 Healthcare brands.
信达生物制药 (Innovent Biologics) is a 致力于开发、生产和销售全球患者负担得起的高质量生物药品。. 致力于开发、生产和销售全球患者负担得起的高质量生物药品。.
| Brand Name | 信达生物制药 (Innovent Biologics) |
|---|---|
| Domain | innoventbio.com |
| Industry | Healthcare |
| Main Competitors | BeiGene (85/100), Junshi Biosciences (68/100), Akeso Biopharma (71/100), Jiangsu Hengrui Medicine (62/100), Zai Lab (77/100), WuXi Biologics (63/100) |
Moz Domain Authority 41/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #681,763 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "致力于开发、生产和销售全球患者负担得起的高质量生物药品。" (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: No structured data or Open Graph tags detected. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Content is ZH-only, limiting citation in English-language AI answers.
Detected tech stack: Nginx, Vue.
Social footprint: verified profiles on LinkedIn, Facebook, X (Twitter), Instagram; no detected presence on YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is 信达生物制药 (Innovent Biologics)?", Claude could identify the brand as of October 2026. Innovent Biologics is a major Chinese biopharmaceutical company based in Suzhou that develops and commercializes oncology, autoimmune, cardiovascular, and metabolic disease drugs, many of which are high-quality monoclonal antibodies and biosimilars. Its flagship product is Tyvyt Best known for Developing Tyvyt (sintilimab), one of China's leading PD-1 inhibitor cancer drugs.
When asked "Best brands similar to 信达生物制药 (Innovent Biologics)?", Claude would recommend 信达生物制药 (Innovent Biologics) as of October 2026. It's one of China's leading biopharma companies with a strong pipeline and international partnerships, making it a natural name to mention alongside other major Chinese or Asian biotech firms.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
信达生物制药 (Innovent Biologics)'s main competitors in Healthcare: BeiGene (85/100), Junshi Biosciences (68/100), Akeso Biopharma (71/100), Jiangsu Hengrui Medicine (62/100), Zai Lab (77/100).
Sources: Brand Analyzer scan
信达生物制药 (Innovent Biologics) has low AI-search visibility, scoring 18/100 on Brand Analyzer's AI visibility composite (visibility 5, trust 19, recommendation 42). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
信达生物制药 (Innovent Biologics) scores 42/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
信达生物制药（Innovent Biologics）是一家中国生物制药企业，定位为中国领先的创新生物制药企业，致力于通过自主研发和国际合作推动全球患者获得高质量生物药品。
信达生物制药致力于开发、生产和销售全球患者负担得起的高质量生物药品，依托自主研发的技术平台，专注于肿瘤、自身免疫疾病和代谢疾病等领域的创新生物药研发。
信达生物制药 (Innovent Biologics) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
信达生物制药提供用于治疗肿瘤、自身免疫疾病和代谢疾病的生物药品，这些产品基于公司自主研发的技术平台开发，旨在为全球患者提供高质量且可负担的治疗选择。
信达生物制药的产品和服务面向肿瘤、自身免疫疾病及代谢疾病患者，同时服务于医疗机构、医生以及医药行业合作伙伴。
信达生物制药以在肿瘤、自身免疫疾病和代谢疾病领域开发创新生物药而知名，强调利用自主研发技术平台提供高质量且可负担的治疗方案。
信达生物制药 (Innovent Biologics) scores 18/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
信达生物制药 (Innovent Biologics) has a weak AI-visibility profile at 18/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (42/100) and its weakest is visibility (5/100). It benefits from a global traffic rank of #681,763 (Tranco), a Moz Domain Authority of 41/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and thin schema.org structured data. In a live check, Claude could already identify 信达生物制药 (Innovent Biologics) from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to 信达生物制药 (Innovent Biologics): Innomar Strategies (67/100), infologiQ (67/100), Integral Diagnostics (67/100), Interacoustics (67/100).
A step up - brands to learn from: ZT Corporate (71/100), Zorgnet-Icuro (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.